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Background: Technetium-labeled agents, which are most often used for assessing myocardial perfusion in
myocardial perfusion scintigraphy (MPS), are cleared by the liver and excreted by the biliary system. Spillover from
extra-cardiac activity into the myocardium, especially the inferior wall, might conceal defects and lower the
diagnostic accuracy of the study. The objective was to determine rules of thumb for when reacquisition is useful
due to high extra-cardiac uptake, i.e., when interpretation of the studies was affected by poor image quality.
Methods: Patients admitted to MPS at any of the three study sites, who also underwent a reacquisition due to
high extra-cardiac uptake were included. Image quality was assessed by ten technologists on a scale ranging from
1 to 5. Interpretations regarding the presence/absence of ischemia/infarction, including the certainty of the
diagnosis, were made by three physicians.
Results: There was a statistically significant increase in image quality between the first and the repeated acquisition
(1,256 cases of increased quality at the repeated study (66%), 134 cases of decreased quality at the repeated study
(7%), 510 cases of unchanged quality (27%) P < 0.0001). The number of equivocal studies, interpreted by physicians,
decreased when evaluating the repeated studies compared to the first studies for all physicians, both for the
interpretations of ischemia and for infarction. Receiver operating characteristic analyses revealed that for both
endpoints (ischemia, infarction) and all physicians, the optimal cutoff point for performing a reacquisition was
between quality categories 2 and 3.
Conclusion: This study indicates that repeat acquisition is useful when (1) the intensity of the extra-cardiac uptake
is equal to or higher than the cardiac uptake when there is no separation between the extra-cardiac uptake and
the inferior cardiac wall and (2) when the intensity of the extra-cardiac uptake is higher than the cardiac uptake
when there is a separation between the extra-cardiac uptake and the inferior wall of less than one cardiac wall.
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Figure 1 Instructions to technologists for how to grade quality
of the images. ECA, extra-cardiac uptake; MU, myocardial uptake.
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Myocardial perfusion scintigraphy (MPS) is widely
regarded as a clinically useful noninvasive imaging method
for the diagnosis of suspected coronary artery disease,
identification of culprit lesions and risk assessment [1-4].
Technetium-labeled agents, which are most often used for
assessing myocardial perfusion, are cleared by the liver
and excreted by the biliary system. Activity in the
subdiaphragmatic organs can interfere with evaluation of
perfusion in two general ways. Spillover from the extra-
cardiac activity into the myocardium, especially the infer-
ior wall, might conceal defects and lower the diagnostic
accuracy of the study. The spillover is a result of the lim-
ited spatial resolution of the camera system and scattered
photons that are detected in the myocardial area but em-
anate from the extra-cardiac activity. High extra-cardiac
activity can also result in decreased activity in the adjacent
myocardium, if filtered back-projection (FBP) is used [5].
This latter artifact does not occur if iterative reconstruc-
tion such as ordered subset expectation maximization
(OSEM) reconstruction is used.
The artifacts due to high extra-cardiac activity are pa-
tient dependent, and their impact on the image inter-
pretation is difficult to predict. A common way to
handle problems regarding extra-cardiac activity in clin-
ical routine is to perform repeat acquisitions when the
extra-cardiac activity is assumed to have cleared from
the vicinity of the heart. There is limited clinical evi-
dence as to the usefulness of repeat acquisitions and
when they should be performed.
The objective of the study was to determine rules of
thumb for when reacquisition is useful due to high
extra-cardiac uptake adjacent to the heart, i.e., when in-
terpretation of the studies is affected by poor image
quality. In this study, only extra-cardiac activity resulting
in spillover was investigated.
Methods
The study population includes patients who underwent a
MPS at Sahlgrenska University Hospital, Gothenburg,
Sweden, Skåne University Hospital, Malmö, Sweden, or
Odense University Hospital, Odense, Denmark. Only pa-
tients who had a reacquisition according to clinical rou-
tine due to high extra-cardiac uptake were included. Mean
time between the first and the repeat acquisition was 88
min (standard deviation 37 min). In cases of several
reacquisitions on the same patient, only one was included.
All the images were presented to three or four technolo-
gists at each site (three from Gothenburg and Odense, re-
spectively, and four from Malmö), using a modified
version of EXINI heartTM (EXINI Diagnostics, Lund,
Sweden), where only slice images and polar plots were
provided. No quantification (scoring values, blackouts,
etc.) was presented. In total, 1,900 evaluations wereperformed (92 patients from Gothenburg, 25 patients
from Malmö, 74 patients from Odense). No clinical infor-
mation about the patient or the study was available to the
technologists. The technologists judged image quality on a
scale ranging from 1 to 5; 1 being worst (Figure 1), and
judged the first and the repeated acquisition images separ-
ately and in random order. The judgment was based on
the distance between the extra-cardiac activity and the
heart wall as well as on the relative intensities of extra-
cardiac activity and myocardium, which was determined
by visual assessment. Illustrative examples are shown in
Figure 2. This scale, and examples for each grade, had
been agreed on at a joint meeting at the start of the study.
For the evaluations made by physicians, all patients
who did not have a corresponding stress or a rest study
to the first or reacquisition available were excluded. Six-
teen new Gothenburg patients were also added in order
to increase the statistical power, which were not in-
cluded in the quality evaluation performed by technolo-
gists. In total, 112 patients from Gothenburg, 5 patients
from Malmö, and 17 patients from Odense were
included. Three experienced physicians, one from each
study center, independently classified the studies (134
patients × 2 studies) with regard to the presence/absence
of ischemia/infarction in grades from 1 to 5 (1 = no
ischemia/infarction, 2 = probably no ischemia/infarction,
3 = equivocal, 4 = probable ischemia/infarction, and
5 = certain ischemia/infarction). The physicians were
blinded to any patient data, except gender, including
which studies belonged to the same patient and if the
study was the first acquisition or the reacquisition. They
did not know if the extra-cardiac uptake decreased at
the reacquisition. Only slice images and polar plots were
presented, without quantification such as scoring values.
In the evaluation of the interrelationships between the
technologists’ quality assessment and the physicians’
confidence in rating myocardial ischemia and infarction
Figure 2 Examples of the grading of image quality (grading 1
to 5).
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were evaluated by all ten technologists and three physi-
cians. Of these, 91 patients were from Gothenburg, 4
from Malmö, and 16 from Odense.
The study was performed in accordance with the prin-
ciples of the Declaration of Helsinki, and met legal re-
quirements (including ethical and radiation protection
regulations). According to Swedish law (SFS 2003:460), a
study regarded as quality work does not need formal ap-
proval from local research ethics committee.
Myocardial perfusion scintigraphy
The MPS tests were performed per clinical routine in the
departments, using a 2-day gated stress/gated rest proto-
col in Malmö and Odense while a 2-day non-gated stress/
gated rest protocol was used in Gothenburg. The proto-
cols used at the different sites are described in Table 1.
Statistical methods
Descriptive statistics were performed according to data
type; i.e., categorical variables were presented as frequen-
cies and percentages, continuous variables were analyzed
by mean, standard deviation, number or observations,
minimum, median, maximum. Inter-observer agreement
was investigated by means of Fleiss’ kappa [6,7] and
respective 95% confidence intervals (95% CI) which wereassessed using bootstrapping techniques [8]. Changes
from first to second acquisition were assessed by
McNemar’s test. Interrelationships between the technolo-
gists’ quality assessment and the physicians’ confidence in
rating myocardial ischemia and infarction (measured on a
5-point scale) were explored by generalized logit regres-
sion model fitting in which the dependent variable was
binary (being definitely sure of either existent or nonexis-
tent ischemia/infarction versus indifference or possible ex-
istent or nonexistent ischemia/infarction). Independent
variables were the technologists’ quality assessment and
the acquisition number (first or second). The clustered
nature of the data on a patient level (i.e., repeated evalu-
ation of the same images by several technologists) was
accounted for in order to use appropriate standard errors
for the calculation of 95% CI for point estimates. Analyses
were done for each physician separately. Receiver operat-
ing characteristic (ROC) curve analysis was performed on
the technologists’ quality assessment to estimate the data-
driven optimal threshold for maximizing the physicians’
confidence in rating myocardial ischemia and infarction.
The optimal cutoff value was calculated as the point clos-
est to the (0,1) point in the upper left corner of the ROC
graph [9]. For the association between technologists’ and
physicians’ assessments, only studies which included all
assessments were included (a total of 111 studies). A sub-
analysis was performed for the interrelationships between
the technologists’ quality assessment and the physicians’
confidence in rating myocardial ischemia and infarction,
for the different reconstruction methods (FBP, Gothenburg
and Malmö and OSEM, Odense).
All of the hypothesis testing was done for exploratory
purposes only without adjustment for multiple testing.
Significance level was 5% (two-sided). All analyses were
performed using SAS 9.1.3 (SAS Institute Inc., Cary,
NC, USA) or Stata/MP 12.1 (StataCorp LP, College Sta-
tion, Texas, USA).
Results and discussion
Quality assessment made by nuclear medicine
technologists
The classifications made by the nuclear medicine tech-
nologists for the first and repeat acquisition are shown
in Table 2. There was a statistically significant increase
in image quality between the first and the repeat acquisi-
tion (1,256 cases of increased quality at the repeated
study (66%), 134 cases of decreased quality at the re-
peated study (7%), and 510 cases of unchanged quality
(27%); P < 0.0001).
The kappa values for the quality assessments done by
the ten technologists were 0.36 (95% CI 0.31 to 0.41)
and 0.40 (0.36 to 0.44) in the first run and second run,
respectively, reflecting a fair agreement. The agreement
was moderate in Gothenburg and Odense in both
Table 1 Imaging protocols used at the different sites
Gothenburg Malmö Odense
Radiopharmaceutical Sestamibi Tetrofosmin Sestamibi/tetrofosmin
Administered activity (MBq) 600 600 800 to 1,000
Method of stress Adenosine or maximal exercise Adenosine or maximal exercise Adenosine with light exercise
Time elapsed between tracer injection
and measurement (min)
60 60 60
Camera system(s) GE Infinia/Millenium Siemens E.Cam GE Ventri
Collimator LEHR LEHR LEHR
N of measured projections 60 over 180° starting at 45°
right anterior oblique
64 over 180° starting at 45°
right anterior oblique
64 over 180° starting at 45°
right anterior oblique
Acquisition time (second per projection) 40 20 20
Patient position Supine Supine Supine
Pixel size after reconstruction (mm) 6.9 6.6 6.4
Reconstruction method FBP FBP OSEM
LEHR, low energy high resolution; FBP, filtered back-projection; OSEM, ordered subset expectation maximization.
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kappa 0.48 (0.40 to 0.57), second run 0.49 (0.43 to 0.56),
Malmö = first run kappa 0.30 (0.24 to 0.37), second run
0.39 (0.34 to 0.45), Odense = kappa first run 0.40 (0.31
to 0.49), second run 0.47 (0.40 to 0.54).
Interpretations made by physicians
The number of equivocal studies decreased when evalu-
ating the repeated studies compared to the first studies
for all physicians, both for the interpretations of ische-
mia and for infarction. For the first physician, the num-
ber of equivocal studies decreased from 16 at the first
acquisition to 8 at the reacquisition for ischemia (P =
0.10) and from 9 to 8 for infarction (P = 0.99). For the
second physician, the number of equivocal studies de-
creased from 50 to 21 for ischemia (P < 0.0001) and
from 24 to 11 for infarction (P = 0.007). For the third
physician, the numbers decreased from 40 to 21 for is-
chemia (P = 0.002) and from 21 to 17 for infarction (P =
0.59). Cross-tabulations of quality assessment with re-
spect to ischemia and infarction made by the physiciansTable 2 Cross-tabulation of quality assessment made by
nuclear medicine technologists (first versus second
acquisition)
First acquisition Second acquisition
1 2 3 4 5 Total
1 54 90 114 68 51 377
2 72 265 345 193 173 1,048
3 8 34 88 98 84 312
4 1 4 6 19 40 70
5 1 0 2 6 84 93
Total 136 393 555 384 432 1,900
Improvements in quality from first to second acquisition are to be found
above the main diagonal (i.e., in the upper right corner of the table).for the first and repeat acquisition are shown in Table 3
(ischemia) and Table 4 (infarction).
Interrelationships between the technologists’ quality
assessment and the physicians’ confidence in rating
myocardial ischemia and infarction
We modeled the influence of the technologists’ quality
assessment on the physicians’ confidence in rating ische-
mia and infarction (very sure versus less sure or equivo-
cal). With respect to ischemia, one unit increase in the
technologists’ quality assessment led on average to a 1.3-
to 1.9-fold statistically significant increased chance of
the physician being very confident with his/her evalu-
ation (either absence or presence of ischemia), whereas
the acquisition number did not have a statistically sig-
nificant influence on the physicians’ confidence (Table 5).
Regarding infarction, only for one physician did one unit
increase in the technologists’ quality assessment lead on
average to a 1.4-fold statistically significant increased
chance of the physician being very confident with his/
her evaluation (95% CI, 1.1 to 1.8, P = 0.01). Again, the
acquisition number did not have a statistically significantTable 3 Cross-tabulation of diagnosis with respect to
ischemia made by physicians (first versus second
acquisition)
First acquisition Second acquisition
1 2 3 4 5 Total
1 56 15 4 2 0 77
2 36 45 7 17 7 112
3 10 45 31 11 9 106
4 8 17 6 9 10 50
5 4 4 2 10 25 45
Total 114 126 50 49 51 390
1 = no ischemia; 3 = equivocal; 5 = certain ischemia.
Table 4 Cross-tabulation of diagnosis with respect to
infarction made by physicians (first versus second
acquisition)
First acquisition Second acquisition
1 2 3 4 5 Total
1 112 27 4 0 0 143
2 30 58 11 9 1 109
3 4 22 14 11 3 54
4 2 7 5 11 16 41
5 0 2 2 4 35 43
Total 148 116 36 35 55 390
1 = no infarction; 3 = equivocal; 5 = certain infarction.
Johansen et al. EJNMMI Research 2013, 3:20 Page 5 of 8
http://www.ejnmmires.com/content/3/1/20influence on the physicians’ confidence. Table 6 shows the
results from the subgroup analysis on Odense patients
(OSEM), and Gothenburg and Malmö patients (FBP).
Table 7 shows the movements between the quality classes
from the first to the repeat acquisition by reconstruction
method. Movements are shown by incremental improve-
ment and worsening from the first to the second acquisi-
tion (e.g. ‘improvement by one point’) and were comparable
for FBP and OSEM.
ROC analyses revealed that for both endpoints (ische-
mia, infarction) and all physicians, the optimal cutoff
point for performing a repeat acquisition was a technol-
ogists’ quality assessment between categories 2 and 3.
With respect to ischemia, the area under the ROC curve
varied from 0.59 to 0.71 between the three physicians;
regarding infarction, it varied from 0.53 to 0.62 (data not
shown). Figure 3 shows the ROC curve for physician 1
with respect to ischemia. The optimal cutoff value, i.e.,
the point closest to the (0,1) point in the upper left cor-
ner of the ROC graph, relates to a cutoff between cat-
egories 2 and 3 in the technologists’ rating. This means
that the technologists’ scores equal to or larger than 3
were the best predictor for strong confidence in the phy-
sicians’ rating; while technologists’ scores of 1 or 2 were
the best predictor for limited confidence in the physi-
cians’ rating, as compared to other possible cutoff points
for the technologists’ scores.Table 5 Results from generalized logit regression model fittin
Endpoint Physician Technologists' quality assess
Odds ratio 95% CI
Ischemia 1 1.9 1.4 2.6
2 1.8 1.4 2.3
3 1.3 1.03 1.6
Infarction 1 1.1 0.8 1.5
2 1.4 1.1 1.8
3 1.1 0.8 1.4Discussion
In this study we wanted to determine rules of thumb
for when reacquisition is useful due to high extra-cardiac
uptake adjacent to the heart, i.e., when interpretation
of the studies is affected by poor image quality. The
European Council on Nuclear Cardiology (joint group
of the European Association of Nuclear Medicine and of
the European Association of Nuclear Medicine and of the
European Society of Cardiology) wrote in their European
procedural guidelines from 2005 that MPS images should
be reviewed for the presence of extra-cardiac ‘hot spots’ so
close to the left ventricle that they interfere with recon-
struction and processing (e.g., lung, liver, gall bladder, and
muscle) and to consider whether repeated acquisition is
relevant after a time interval [10]. However, it is not clear
from the guidelines when extra-cardiac activity interferes
with reconstruction and processing, i.e., affects image
quality, and should be repeated.
In the present study, we found significantly higher
quality in the repeat acquisition than in the first. Since
the technologists were not aware of the order of the ac-
quisitions, we can conclude that it is useful to repeat the
acquisition when high extra-cardiac activity is present.
We also found that for both ischemia and infarction, the
optimal cutoff point for performing a repeat acquisition
was a technologists’ quality assessment between categor-
ies 2 and 3. Thus, based on this study, reacquisition is
recommended when the intensity of the extra-cardiac
uptake is equal to or higher than the cardiac uptake
when there is no separation between the extra-cardiac
uptake and the inferior cardiac wall, and when the inten-
sity of the extra-cardiac uptake is higher than the cardiac
uptake when there is a separation between the extra-
cardiac uptake and the inferior wall of less than one car-
diac wall. The relationship between the technologists’
quality assessment and the physicians’ confidence in
assessing ischemia was stronger than the relationship be-
tween the technologists’ quality assessment and the phy-
sicians’ confidence in assessing infarction. The subgroup
analyses for the interrelationships between the technolo-
gists’ quality assessment and the physicians’ confidence
rating in myocardial ischemia and infarction revealedg
ment First or second acquisition
P value Odds ratio 95% CI P value
<0.0001 1.1 0.6 2.0 0.86
<0.0001 1.5 0.8 2.8 0.23
0.03 1.0 0.5 1.8 0.93
0.61 0.9 0.5 1.8 0.76
0.01 1.2 0.7 2.1 0.48
0.58 1.0 0.6 1.9 0.94
Table 6 Results from generalized logit regression model fitting—subgroup analysis
Subgroup Endpoint Physician Technologists' quality assessment First or second acquisition
Odds ratio 95% CI P value Odds ratio 95% CI P value
OSEMa Ischemia 1 1.2 0.4 3.5 0.80 2.3 0.3 22.1 0.49
2 2.0 0.7 5.6 0.21 0.4 0.1 2.7 0.38
3 1.6 0.7 3.7 0.32 0.4 0.1 3.1 0.36
Infarction 1 0.9 0.3 2.6 0.86 0.6 0.1 5.6 0.67
2 1.5 0.5 5.1 0.51 0.7 0.1 3.6 0.67
3 1.1 0.4 3.5 0.86 3.3 0.3 37.7 0.33
FBPb Ischemia 1 1.9 1.4 2.6 <0.0001 0.9 0.5 1.8 0.83
2 1.9 1.4 2.5 <0.0001 1.8 0.9 3.8 0.10
3 1.3 1.02 1.7 0.03 1.1 0.6 2.2 0.80
Infarction 1 1.0 0.7 1.5 0.86 0.9 0.5 1.9 0.79
2 1.4 1.0 1.8 0.03 1.3 0.7 2.2 0.44
3 1.1 0.8 1.4 0.60 0.9 0.5 1.7 0.77
aOSEM, Odense patients; bFBP, Gothenburg and Malmö patients.
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tients from Gothenburg and Malmö, as 95 out of 111
patients were from Gothenburg and Malmö. The sub-
group results relating to Odense patients underlay larger
variation due to the limited number of patients, leading
to wider confidence intervals, but showed the same ten-
dencies as the main result.
In a recent simulation study from our group, similar
results were found [11]. In that study, MPS with inferior
defects of different sizes as well as extra-cardiac uptake
with different intensities and distances from the inferior
cardiac wall were Monte Carlo simulated. The EXINI
heartTM software was used to evaluate the extent and se-
verity of the defects. The conclusion from the study was
that reacquisition should be considered when the extra-
cardiac intensity is equal to the myocardium intensity at
a distance of 0.5 cardiac wall thickness, or extra-cardiacTable 7 Movements between the classes from the first to
the second acquisition by reconstruction method
Change from first to
second acquisition
Reconstruction method Total (%)
FBP (%) OSEM (%)
Improvement by 4 points 29 (2.5) 22 (3) 51 (2.7)
Improvement by 3 points 156 (13.4) 85 (11.6) 241 (12.7)
Improvement by 2 points 226 (19.4) 165 (22.5) 391 (20.6)
Improvement by 1 point 345 (29.6) 228 (31.1) 573 (30.2)
No change 340 (29.1) 170 (23.2) 510 (26.8)
Worsening by 1 point 62 (5.3) 56 (7.6) 118 (6.2)
Worsening by 2 points 8 (0.7) 6 (0.8) 14 (0.7)
Worsening by 3 points - 1 (0.1) 1 (0.05)
Worsening by 4 points - 1 (0.1) 1 (0.05)
Total 1,166 (100) 734 (100) 1,900 (100)
FBP, filtered back-projection; OSEM, ordered subset expectation maximization.intensity twice the myocardium intensity at a distance of
1 cardiac wall thickness. For extra-cardiac intensities
that are half (or less than half ) the intensity of the myo-
cardium, no reacquisition is necessary. Previous studies
have investigated the impact of high extra-cardiac up-
take, especially high hepatic uptake, on the quantitative
analysis of MPS images, using static phantoms [12-14].
Heller et al. [13] concluded that the addition of attenu-
ation correction in the presence of extra-cardiac activity
can have complex effects on maximum likelihood recon-
struction with nonuniform attenuation correction, which
depends on the amount of extra-cardiac activity and pat-
tern of attenuation. It should be noted that we only used
nonattenuation-corrected images in the present study,
and that the results might be different when using
attenuation-corrected images.Figure 3 ROC curve for physician 1 with respect to ischemia.
The dots, starting from the lower left corner, in the ROC curve,
represent a cutoff of more than 5, between 4 and 5, between 3 and
4, between 2 and 3, between 1 and 2, and less than 1.
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of patients included, that it was a multi-center study and
that we have used several technologists and physicians for
assessments of image quality and image interpretation.
There were differences in the assessments made by both
technologists and physicians, which is true for all diagnos-
tic examinations. Thus, this study reflects a more real clin-
ical setting compared to simulation studies or single-
center studies, which commonly uses fewer physicians/
technologists that are more likely to agree on assessments.
Several previous studies have investigated the number of
repeated studies with regard to time from injection to
image acquisition. Lyngholm et al. [15] studied the effect of
time and food on upper abdominal activity in 99mTc-
tetrofosmin MPS. They graded each study on a 5-point
semiquantitative scale. However, no real rule as when re-
acquisition was necessary was given in that study. In a
study by Giorgetti et al. [16], the feasibility of early-image
tetrofosmin protocol was investigated. Two observers visu-
ally analyzed the quality of the images using a 4-point scale,
without further describing the criteria for the assessment.
In our study, the color scale used was the one used rou-
tinely in Gothenburg. The technologists from Gothenburg
who evaluated the images were more familiar with the
color scale used than the technologists from Malmö and
Odense. Also, in Malmö, four technologists assessed
image quality as compared to three from Gothenburg and
Odense. This could partly explain the differences in kappa
values for different sites with regard to quality assessment.
There were 84 evaluations of 5, i.e., no extra-cardiac activ-
ity at all, in both first and second acquisition, which could
be explained by reacquisition performed due to movement
alone in at least six patients. One of the physicians
assessed far fewer studies as ‘equivocal’ than the other
two. This could partly be explained by that physician be-
ing more used to the EXINI heart™ software package
which was used for image interpretation.
Limitations of the study
The paper should be considered in the light of some
limitations. We were not able to verify the diagnosis
made by the physicians with an independent reference
technique or follow-up of the patients. Also, different
protocols and reconstruction parameters were used at
the different study sites. Another limitation is that no
attenuation-corrected images were available for analysis.
No analysis of high extra-cardiac uptake resulting in de-
creased activity in the adjacent myocardium due to FBP
was performed.
Conclusion
Reacquisition is recommended when the intensity of the
extra-cardiac uptake is equal to or higher than the car-
diac uptake when there is no separation between theextra-cardiac uptake and the inferior cardiac wall and
when the intensity of the extra-cardiac uptake is higher
than the cardiac uptake when there is a separation be-
tween the extra-cardiac uptake and the inferior wall of
less than one cardiac wall. We also found that the rela-
tionship between the technologists’ quality assessment
and the physicians’ confidence in assessing ischemia was
stronger than the relationship between the technologists’
quality assessment and the physicians’ confidence in
assessing infarction.
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